James Dondero: Leading HighLand Capital Management Forward
James Dondero is now based in Dallas, Texas. For the past 2 decades, Jim has been heading up Highland Capital Management, the investment banking firm that he founded in 1993. The firm offers every service from REITs and ETFs to mutual funds and private equity funds to hedge funds, CLOs and even institutional separate accounts. The firm has two speciality areas. The first area they are known for is creating credit based solutions for global clients who are retail investors or institutional investors.
James Dondero is certified as a Certified Public Accountant, Chartered Financial Analyst and Certified Management Accountant. Dondero also serves on the board of several organizations in the community, including MGM Studios, CCS Medical, Cornerstone Healthcare, American Banknote and NexBank. But before he was on these boards or leading Highland Capital Management, Dondero worked for the Morgan Guaranty training program, a Protective Life GIC subsidiary and American Express. He worked as a Chief Investment Officer, analyst, corporate bond analyst and portfolio manager. Dondero worked in these jobs for about 10 years and then decided to go on and start his own firm.
Dondero’s firm was recently discussed in the news after they filed their 13F for the third quarter of 2015. Octa Finance was just one of the news outlets that reviewed the document and have since released a summary of their findings. The fund made 69 new purchases, including 67 million dollars for Spdr S&P 500 Etf Tr, 23 millions dollars for Amazon Com Inc, 17 million dollars for Eagle Pharmaceutical Inc, 17 million dollars for Danaher Corp Del and 15 million dollars for Intra Cellular Therapies Inc. Those were also the 5 biggest positions that the firm earned during the third quarter.
These top buys have taken up big positions in Highland Capital Management’s portfolio. The Spdr S&P 500 Etf Tr represents 1.96 percent of the firm’s portfolio. The Amazon Com Inc represents 0.68 percent of the firm’s portfolio. The Eagle Pharmaceuticals Inc now represents 0.52 percent of the portfolio. The Danaher Corp Del takes up 0.50 percent of the firm’s portfolio and Intra Cellular Therapies Inc represents 0.46 percent of the portfolio. There was a also a major sector change for the firm during the third quarter. The firm largely left the health care and the finance sectors.
To read the entire article, please go here: http://www.octafinance.com/highland-capital-management-top-10-holdings-in-q3-2015/352793/